Literature DB >> 1312833

Endothelin and structurally related analogs distinguish between endothelin receptor subtypes.

R L Panek1, T C Major, G P Hingorani, A M Doherty, D G Taylor, S T Rapundalo.   

Abstract

The endothelin (ET) analog ET-1[1,3,11,15-Ala] was compared with ET-1, ET-2, ET-3 and sarafotoxins (SRTX) S6b and S6c for receptor binding and function. All the peptides exhibited high affinity binding and contracted rabbit pulmonary artery with near equal potency. In rat aorta both ET-3 and ET-1 [1,3,11,15-Ala] bound with much lower affinity than ET-1 while ET-3 displayed weak contractile potency and ET-1 [1,3,11,15-Ala] and SRTX-c were inactive. In rat left atria, ET-1 [1,3,11,15-Ala] and SRTX-c were weak inhibitors of binding and were also functionally inactive, whereas ET-1, ET-2, ET-3, and SRTX-b were equipotent in producing contractile responses. The data support the idea of there being a predominance of ETA receptors in rat aorta and ETB receptors in rabbit pulmonary artery. In rat left atria, the ET receptor could not be readily classified into ETA or ETB and suggests the existence of a new receptor subtype.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312833     DOI: 10.1016/0006-291x(92)90519-q

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  Evidence that ET-1, but not ET-3 and S6b, ET(A)-receptor mediated contractions in isolated rat mesenteric arteries are modulated by co-activation of ET(B) receptors.

Authors:  M Adner; N Shankley; L Edvinsson
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

Review 2.  Endothelins. Vascular actions and clinical implications.

Authors:  T Sakurai; K Goto
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

3.  Differential localization of endothelin ETA and ETB binding sites in human placenta.

Authors:  R A Rutherford; J Wharton; A McCarthy; L Gordon; M H Sullivan; M G Elder; J M Polak
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

4.  Transcriptional down-regulation of the rabbit pulmonary artery endothelin B receptor during phenotypic modulation.

Authors:  R Owe-Young; C G Schyvens; R A Qasabian; A D Conigrave; P S Macdonald; D J Williamson
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

5.  Endothelin receptor subtypes in human and guinea-pig pulmonary tissues.

Authors:  D W Hay; M A Luttmann; W C Hubbard; B J Undem
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

6.  Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus.

Authors:  D W Hay; M A Luttmann; G Beck; E H Ohlstein
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

7.  Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788.

Authors:  K Ishikawa; M Ihara; K Noguchi; T Mase; N Mino; T Saeki; T Fukuroda; T Fukami; S Ozaki; T Nagase
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

8.  Endothelin-1 does not mediate hypoxic vasoconstriction in canine isolated blood vessels: effect of BQ-123.

Authors:  S A Douglas; L M Vickery-Clark; E H Ohlstein
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

9.  SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist.

Authors:  E H Ohlstein; P Nambi; S A Douglas; R M Edwards; M Gellai; A Lago; J D Leber; R D Cousins; A Gao; J S Frazee
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

10.  Characterization of three non-peptide endothelin receptor ligands using human cloned ETA and ETB receptors.

Authors:  K W Buchan; C Alldus; C Christodoulou; K L Clark; C W Dykes; M J Sumner; D M Wallace; D G White; I S Watts
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.